Brookside Mezzanine Partners invests in Dermatology Associates

Brookside Mezzanine Partners has made an undisclosed investment in Dermatology Associates, a portfolio company of Candescent Partners. Headquartered in Tyler, Texas, Dermatology Associates is a provider of clinical dermatology and pathology lab services in the Eastern Texas region.


Brookside Mezzanine Partners is pleased to announce its investment in Dermatology Associates, an existing portfolio company of Candescent Partners. Founded in 1990 and headquartered in Tyler, TX, Dermatology Associates is a leading provider of clinical dermatology and pathology lab services in the Eastern Texas region. Dermatology Associates also provides additional elective services, including laser hair removal, tattoo removal, fraxel laser skin restoration and other aesthetical services.
Brookside Mezzanine Partners provided senior debt and preferred equity to facilitate Dermatology Associates’ acquisition of The Dermatology Skin & Cancer Center (“DSCC”), a leading provider of clinical dermatology and pathology lab services in Missouri and Kansas. DSCC has been a pioneer in Mohs Microscopic Surgery for the treatment of high risk skin cancers. The combination of Dermatology Associates and DSCC (together, the “Company”) results in an organization with 25 physicians providing dermatology services via 14 locations in Texas, Kansas and Missouri, handling nearly 150,000 patient visits this year.
Headquartered in Boston, MA, Candescent Partners is a private equity firm that invests in the acquisition, growth and recapitalization of lower middle market companies in healthcare services, business services, software and consumer products and services.
About Brookside Mezzanine Partners
Founded in 2001, Brookside Mezzanine Partners manages in excess of $500 million across three mezzanine funds. The Firm is a leading provider of subordinated debt and minority equity capital to small and mid-sized companies throughout the United States. We invest in both sponsored and non-sponsored transactions and provide junior capital and unitranche financing to support buyouts, leveraged recapitalizations, strategic acquisitions, dividends and growth capital.
Please contact us or visit our website at for additional information.

Do you want exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more? Get your FREE trial to Buyouts! Or subscribe now!

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

We will not send you spam, and we don't share your email address with 3rd parties.